Drug intelligence / Profile preview

ibuprofen + ondansetron + misoprostol

Development stage
Unknown
Lead developer
Boots
Modality
Small Molecules
Administration
Oral, Intravenous, Intramuscular, Sublingual, Buccal, Vaginal, Rectal
01

Overview

This is a combination of three small molecule drugs—ibuprofen, ondansetron, and misoprostol—used adjunctively in the context of medication abortion or for managing pain and gastrointestinal side effects associated with uterine procedures. - **Ibuprofen** is a nonsteroidal anti-inflammatory drug (NSAID) that acts as an analgesic and antipyretic by inhibiting cyclooxygenase enzymes (COX-1 and COX-2), thereby reducing prostaglandin synthesis involved in pain, inflammation, and fever. - **Ondansetron** is a selective serotonin 5-HT3 receptor antagonist used to prevent nausea and vomiting by blocking serotonin receptors centrally in the chemoreceptor trigger zone and peripherally on vagal nerve terminals. - **Misoprostol** is a synthetic prostaglandin E1 analog that binds to prostaglandin E1 receptors on gastric parietal cells to reduce acid secretion, increase mucus/bicarbonate production for mucosal protection, and stimulate uterine contractions by binding smooth muscle cells in the uterus. In clinical practice, this combination is not available as a single commercial product but may be prescribed together during medication abortion regimens (with mifepristone) to manage cramping (ibuprofen), prevent or treat nausea/vomiting (ondansetron), and induce uterine contractions/expulsion of pregnancy tissue (misoprostol)[1][3][7][8]. Each component has distinct mechanisms but complementary roles in improving patient comfort during medical abortion.

02

Targets

PTGER3 (Prostaglandin E2 receptor EP3 subtype)HTR3A (5-hydroxytryptamine receptor 3A)PTGER4 (Prostaglandin E2 receptor EP4 subtype)PTGER2 (Prostaglandin E2 receptor EP2)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)PGHS-1 (Prostaglandin G/H Synthase 1)

Beyond the preview

Go deeper on ibuprofen + ondansetron + misoprostol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ibuprofen + ondansetron + misoprostol.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call